Brighton Jones LLC Increases Stock Position in HCA Healthcare, Inc. $HCA

Brighton Jones LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.1% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 3,636 shares of the company’s stock after acquiring an additional 178 shares during the quarter. Brighton Jones LLC’s holdings in HCA Healthcare were worth $1,393,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of HCA. Golden State Wealth Management LLC increased its holdings in HCA Healthcare by 359.3% during the 1st quarter. Golden State Wealth Management LLC now owns 271 shares of the company’s stock worth $94,000 after acquiring an additional 212 shares during the period. Perigon Wealth Management LLC increased its holdings in HCA Healthcare by 2.3% during the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company’s stock worth $621,000 after acquiring an additional 40 shares during the period. Sequoia Financial Advisors LLC increased its holdings in shares of HCA Healthcare by 4.8% in the 1st quarter. Sequoia Financial Advisors LLC now owns 3,225 shares of the company’s stock worth $1,114,000 after buying an additional 149 shares during the last quarter. Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock worth $31,000 after buying an additional 80 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of HCA Healthcare by 21.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,684 shares of the company’s stock worth $8,111,000 after buying an additional 4,236 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 4.8%

Shares of HCA opened at $468.68 on Tuesday. The stock has a market capitalization of $109.67 billion, a P/E ratio of 18.12, a PEG ratio of 1.41 and a beta of 1.40. The firm has a fifty day simple moving average of $416.33 and a two-hundred day simple moving average of $383.23. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $469.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the company posted $4.90 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

Analysts Set New Price Targets

HCA has been the topic of a number of research analyst reports. Sanford C. Bernstein reissued a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a report on Monday. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. KeyCorp upped their price objective on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research note on Monday. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Finally, TD Cowen upped their price objective on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $471.42.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.